super CAR–T cocktail therapy

N/A

Report date: 2025/03/20 15:15:34

Base Information

Drug Namesuper CAR–T cocktail therapy
Drug Alias NameCAR T-cell therapy (Super-T Cell Cancer/Immune Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuper-T Cell Cancer Company
China Registration ClassN/A

Develop Information

Active CompaniesSuper-T Cell Cancer CompanyBiostax Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A